Physician profile
Ann Williams
NPI 1184260572
$4,035.49
in general payments reported to CMS, 2019-2025
29 companies · $976 in 2025
The $976 reported for 2025 was more than what 85% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $745 · 2023: $1,356 · 2024: $724 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,960 · Education: $96.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.04 |
| Education | $96.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $608.42 | 2022-2025 | |
| Genzyme Corporation | $353.42 | 2021-2024 | |
| Inspire Medical Systems, INC. | $250.96 | 2023-2024 | Inspire |
| Axsome Therapeutics, INC. | $235.38 | 2025 | Auvelity |
| Alexion Pharmaceuticals, INC. | $219.93 | 2021-2023 | |
| Gilead Sciences, INC. | $157.68 | 2023-2025 | Livdelzi |
| Amgen INC. | $137.51 | 2025 | |
| Abiomed | $125.69 | 2025 | |
| Alnylam Pharmaceuticals INC. | $121.82 | 2023 | Amvuttra |
| Stemline Therapeutics INC. | $121.82 | 2022 | |
| Viiv Healthcare Company | $121.11 | 2024 | Apretude |
| Biohaven Pharmaceutical Holding Company LTD. | $119.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $116.15 | 2025 | Airsupra |
| Baxter Healthcare | $113.21 | 2022 | |
| Coloplast Corp | $110.94 | 2023-2024 | Titan, Altis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $110.29 | 2023 | Uzedy |
| Acadia Pharmaceuticals INC | $107.68 | 2023 | Nuplazid |
| Novo Nordisk INC | $106.53 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $105.86 | 2022 | |
| Nevro Corp. | $105.64 | 2023 | Senza |
| Edwards Lifesciences Corporation | $100.92 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lilly USA, LLC | $99.37 | 2023 | Jardiance |
| Vertex Pharmaceuticals Incorporated | $96.19 | 2025 | |
| Mylan Specialty L.P. | $93.53 | 2023 | Yupelri |
| Biogen, INC. | $68.61 | 2023 | |
| Sk Life Science, INC. | $60.65 | 2022 | |
| Genentech USA, INC. | $24.82 | 2023 | Rozlytrek, Tecentriq, Alecensa |
| Corcept Therapeutics | $23.82 | 2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $18.41 | 2025 | Fruzaqla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.